Literature DB >> 15765048

Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).

Ji-Jing Pang1, Bo Chang, Norman L Hawes, Ronald E Hurd, Muriel T Davisson, Jie Li, Syed M Noorwez, Ritu Malhotra, J Hugh McDowell, Shalesh Kaushal, William W Hauswirth, Steven Nusinowitz, Debra A Thompson, John R Heckenlively.   

Abstract

PURPOSE: To report the phenotype and characterization of a new, naturally occurring mouse model of hereditary retinal degeneration (rd12).
METHODS: The retinal phenotype of rd12 mice were studied using serial indirect ophthalmoscopy, fundus photography, electroretinography (ERG), genetic analysis including linkage studies and gene identification, immunohistochemistry, and biochemical analysis.
RESULTS: Mice homozygous for the rd12 mutation showed small punctate white spots on fundus examination at 5 months of age. The retina in the rd12 homozygote had a normal appearance at the light microscopic level until 6 weeks of age when occasional voids appeared in the outer segments (OS) of the photoreceptor (PR) cells. The outer nuclear layer (ONL) appeared normal until 3 months of age though more obvious voids were detected in the OS. By 7 months of age, 6 to 8 layers of ONL remained in the mutant retina, and the OS were obviously shorter. The first sign of retinal degeneration was detected at the electron microscopic level around 3 weeks of age when occasional small lipid-like droplets were detected in the retinal pigment epithelium (RPE). By 3 months of age, much larger, lipid-like droplets accumulated in RPE cells accompanied by some OS degeneration. While the histology indicated a relatively slow retinal degeneration in the rd12 homozygous mutant mice, the rod ERG response was profoundly diminished even at 3 weeks of age. Genetic analysis showed that rd12 was an autosomal recessive mutation and mapped to mouse chromosome 3 closely linked to D3Mit19, a location known to be near the mouse Rpe65 gene. Sequence analysis showed that the mouse retinal degeneration is caused by a nonsense mutation in exon 3 of the Rpe65 gene, and the gene symbol for the rd12 mutation has been updated to Rpe65rd12 to reflect this. No RPE65 expression, 11-cis retinal, or rhodopsin could be detected in retinas from rd12 homozygotes, while retinyl esters were found to accumulate in the retinal pigment epithelium (RPE).
CONCLUSIONS: Mutations in the retinal pigment epithelium gene encoding RPE65 cause an early onset autosomal recessive form of human retinitis pigmentosa, known as Leber congenital amaurosis (LCA), which results in blindness or severely impaired vision in children. A naturally arising mouse Rpe65 mutation provides a good model for studying the pathology of human RPE65 mutations and the effects of retinyl ester accumulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765048

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  112 in total

1.  Discovery Genetics - The History and Future of Spontaneous Mutation Research.

Authors:  Muriel T Davisson; David E Bergstrom; Laura G Reinholdt; Leah Rae Donahue
Journal:  Curr Protoc Mouse Biol       Date:  2012-06-01

2.  In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse.

Authors:  Bo Chang; Hemant Khanna; Norman Hawes; David Jimeno; Shirley He; Concepcion Lillo; Sunil K Parapuram; Hong Cheng; Alison Scott; Ron E Hurd; John A Sayer; Edgar A Otto; Massimo Attanasio; John F O'Toole; Genglin Jin; Chengchao Shou; Friedhelm Hildebrandt; David S Williams; John R Heckenlively; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2006-04-21       Impact factor: 6.150

3.  Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.

Authors:  John M Nickerson; Penny Goodman; Micah A Chrenek; Christiana J Bernal; Lennart Berglin; T Michael Redmond; Jeffrey H Boatright
Journal:  Methods Mol Biol       Date:  2012

4.  Photoreceptor cell degeneration in Abcr (-/-) mice.

Authors:  Li Wu; Taka Nagasaki; Janet R Sparrow
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

Review 6.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

7.  Light aversion in mice depends on nonimage-forming irradiance detection.

Authors:  Stewart Thompson; Ana Recober; Timothy W Vogel; Adisa Kuburas; Jessica A Owens; Val C Sheffield; Andrew F Russo; Edwin M Stone
Journal:  Behav Neurosci       Date:  2010-12       Impact factor: 1.912

8.  Genetic modifiers of retinal degeneration in the rd3 mouse.

Authors:  Michael Danciger; Diego Ogando; Haidong Yang; Michael T Matthes; Nicole Yu; Kelly Ahern; Douglas Yasumura; Robert W Williams; Matthew M Lavail
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-14       Impact factor: 4.799

Review 9.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

10.  Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.

Authors:  Jeannette Bennicelli; John Fraser Wright; Andras Komaromy; Jonathan B Jacobs; Bernd Hauck; Olga Zelenaia; Federico Mingozzi; Daniel Hui; Daniel Chung; Tonia S Rex; Zhangyong Wei; Guang Qu; Shangzhen Zhou; Caroline Zeiss; Valder R Arruda; Gregory M Acland; Lou F Dell'Osso; Katherine A High; Albert M Maguire; Jean Bennett
Journal:  Mol Ther       Date:  2008-01-22       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.